Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00717886 · ClinicalTrials.gov registry record · NA
Upper Extremity Lymphatic Mapping for Breast Cancer Patients
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT00717886: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00717886 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00717886, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
This study is being done to see if lymph nodes that drain the arm also drain the breast. An axillary lymph node dissection removes lymph nodes under the arm. It is done to help prevent cancer cells from spreading to the rest of the body. Usually, about 12 to 15 nodes are removed. They are then examined to see if they have cancer cells. Removing these lymph nodes has some side effects. The most common is lymphedema. This is the build-up of fluid in the arm. This study will tell us if it may be possible in the future to identify lymph nodes that just drain the arm. Leaving those nodes may help to reduce the rate of lymphedema for future patients.
Interventions
- RADIATION isosulfan blue dye
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2008-06 |
| Est. Completion | 2009-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00717886
The ClinicalTrials.gov registry entry for NCT00717886 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which isosulfan blue dye is the first listed.
NCT00717886 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00717886 about?
NCT00717886 is a clinical study titled "Upper Extremity Lymphatic Mapping for Breast Cancer Patients". This study is being done to see if lymph nodes that drain the arm also drain the breast. An axillary lymph node dissection removes lymph nodes under the arm. It is done to help prevent cancer cells from spreading to the rest of the body. Usually, about 12 to 15 nodes are removed. They are then exami...
What is the current status of trial NCT00717886?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2008-06. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00717886?
The interventions under investigation include: isosulfan blue dye (RADIATION).
Who is sponsoring clinical trial NCT00717886?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.